News from the FDA/CDC
News from the FDA/CDC
FDA panel deems phenylephrine ineffective
The committee’s next move is to determine if the drug’s status as Generally Recognized as Safe and Effective should be revoked.
Latest News
FDA to step up oversight of cosmetics, assess ‘forever chemicals’
The cosmetic products include makeup products, nail polishes, shaving creams, other grooming products, perfumes, face and body cleansers, hair...
News from the FDA/CDC
FDA okays first-ever new drug for rare bone disorder
The drug reduced annualized heterotopic ossification volume by 54%.
Latest News
Despite recent uptick in cases, leprosy is very rare, expert says
Over the past several years, 150-250 cases of leprosy have been reported each year.
News from the FDA/CDC
FDA approves RSV monoclonal antibody for all infants
The long-acting antibody is given as a single intramuscular injection.
Latest News
More children missing developmental milestones: Survey
No significant change was seen from 2019 to 2021 in how common it was for survey respondents to report children having autism or an intellectual...
News from the FDA/CDC
Malaria is spreading in the U.S. for the first time in 20 years
The CDC said the risk of getting malaria while in the United States “remains extremely low.”
News from the FDA/CDC
FDA approves ritlecitinib for ages 12 and up for alopecia areata
It is the second JAK inhibitor approved for treating alopecia areata, following approval of baricitinib (Olumiant) in June 2022 for alopecia...
News from the FDA/CDC
Severe strep infections rebound after pandemic lull
These infections fell by 25% during the COVID-19 pandemic and were especially low in children.
News from the FDA/CDC
FDA OKs empagliflozin for children with type 2 diabetes
This approval represents only the second oral treatment option for children and adolescents with type 2 diabetes after metformin.
News from the FDA/CDC
FDA panel backs new COVID booster focusing only on variants
Panelists also raised other questions during the meeting, including concerns about moves toward tying COVID vaccinations into the model of annual...